Danicopan Completed Phase 1 Trials for Hepatic Impairment Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT03555539Study of Danicopan in Participants With Hepatic Impairment